AGP Executive Report
Last update: 5 hours agoSwiss Pharma: The FDA is investigating possible tumour risks linked to Novartis’ Zolgensma gene therapy; the company has reported nine tumour cases in children who received it. Business: Swiss dental startup vVardis is targeting a US IPO valuation of up to $4.4 billion, while consumer confidence has fallen to its weakest level since November 2023. Climate: A study links last summer’s heatwave to nearly 1,260 deaths in Switzerland. Public Debate: Demonstrators in Lausanne protested public-sector cuts, as a giant banner outside a data-centre site drew attention to Big Tech. Culture: A new Swiss-Canadian film revisits the 1998 Swissair Flight 111 disaster, which killed all 229 people aboard and left a lasting mark on the country.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
